Thursday, April 03, 2025 1:27:12 AM
MAJI going to run and fast to $1+/share now. Do not wait to buy folks.
https://exousiapro.com/
https://exousiapro.com/wp-content/uploads/2025/02/ExousiaPro-Investor-Presntation-Deck-1-31-25.pdf
https://exousiapro.com/portfolio/
3 real major shareholder updates in 7 days
https://www.otcmarkets.com/stock/MAJI/news
Exousia Pro Has Appointed Matthew Dwyer As Its New PresidentACCESSWIRE | 04/02/2025
Exousia Pro Issues and Update on its FDA Orphan Drug StatusACCESSWIRE | 04/01/2025
Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has BegunACCESSWIRE | 03/25/2025
Exousia Has Successfully Renegotiated Its License AgreementACCESSWIRE | 03/18/2025
https://exousiapro.com/
https://exousiapro.com/wp-content/uploads/2025/02/ExousiaPro-Investor-Presntation-Deck-1-31-25.pdf
https://exousiapro.com/portfolio/
3 real major shareholder updates in 7 days
https://www.otcmarkets.com/stock/MAJI/news
Exousia Pro Has Appointed Matthew Dwyer As Its New PresidentACCESSWIRE | 04/02/2025
Exousia Pro Issues and Update on its FDA Orphan Drug StatusACCESSWIRE | 04/01/2025
Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has BegunACCESSWIRE | 03/25/2025
Exousia Has Successfully Renegotiated Its License AgreementACCESSWIRE | 03/18/2025
Bullish
Recent MAJI News
- NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist • GlobeNewswire Inc. • 05/11/2026 03:53:17 PM
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
